InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: None

Saturday, 12/30/2017 12:35:45 PM

Saturday, December 30, 2017 12:35:45 PM

Post# of 108192
From a new article by Zach Hartman, "PD-1/PD-L1 antibodies are being combined with everything under the sun, so it wouldn't shock me to see big companies like Roche or Bristol-Myers Squibb (NYSE:BMY) scoop up a current partner if they demonstrate something promising."

I expect some smaller oncology companies will be scooped up in the coming year. Link below.

https://seekingalpha.com/article/4133976-zach-hartman-phd-positions-2018-oncology-immunotherapy-focus?app=1&uprof=45&isDirectRoadblock=false

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News